These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 723325)
41. [Myocardial infarct--is prevention possible?]. Nicolaysen R Nord Med; 1971 Apr; 85(15):472-4. PubMed ID: 5574986 [No Abstract] [Full Text] [Related]
42. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate. Kutz K; Schulte A Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479 [TBL] [Abstract][Full Text] [Related]
44. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate. Nye ER; Sutherland WH; Temple Wa N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550 [TBL] [Abstract][Full Text] [Related]
45. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. Wilson DE; Lees RS J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500 [TBL] [Abstract][Full Text] [Related]
46. [Clinical and therapeutic evaluation of a new antilipemic substance]. de Aguiar Magano L Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646 [TBL] [Abstract][Full Text] [Related]
47. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias. Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195 [TBL] [Abstract][Full Text] [Related]
48. [Results of the Coronary Drug Project--routine treatment of infarct patients with serum lipid reductants]. Carlson LA; Rössner S Lakartidningen; 1975 Apr; 72(15):1549-51. PubMed ID: 1094207 [No Abstract] [Full Text] [Related]
49. [Hyperlipiemia and its therapy by clofibrate]. Nakano M; Nakamura Y Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198 [No Abstract] [Full Text] [Related]
50. Design of dietary experiments for preventing myocardial infarction. Frantz ID; Ashman PL J Am Diet Assoc; 1968 Apr; 52(4):293-9. PubMed ID: 5643389 [No Abstract] [Full Text] [Related]
51. [Results of long-term treatment of hyperlipemias]. Reuter W Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:156-9. PubMed ID: 4200339 [No Abstract] [Full Text] [Related]
52. [Serum cholesterol concentration as a risk factor in myocardial infarct]. Geraga W; Gdulewicz T; Kryczka H; Marszal M; Stańczyk I Wiad Lek; 1977 Sep; 30(18):1409-14. PubMed ID: 906503 [No Abstract] [Full Text] [Related]
54. [Should clofibrate still be prescribed?]. Heller F Rev Med Liege; 1982 Apr; 37(7):225-9. PubMed ID: 7089415 [No Abstract] [Full Text] [Related]
55. Warfarin dosage, clofibrate, and age of patient. Eastham RD Br Med J; 1973 Jun; 2(5865):554. PubMed ID: 4714500 [No Abstract] [Full Text] [Related]
56. The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years. Lamm G Eur Heart J; 1981 Aug; 2(4):269-80. PubMed ID: 7028485 [No Abstract] [Full Text] [Related]
57. Trial of clofibrate. Gillam PM Br Med J; 1972 Mar; 1(5801):685. PubMed ID: 4552463 [No Abstract] [Full Text] [Related]
58. [Myocardial infarct and clofibrate--again]. Werkö L Lakartidningen; 1978 Nov; 75(48):4458. PubMed ID: 723325 [No Abstract] [Full Text] [Related]